The CBD Oil Market is led by North America, which accounted for approximately 44.6% of global revenue in 2025. The region benefits from established cannabinoid retail infrastructure, pharmaceutical applications, and consumer demand.

Europe represented approximately 28.4% of global revenue in 2025. Pharmacy distribution, cosmetics applications, and regulatory developments surrounding novel foods are influencing the European market.

Asia-Pacific is the fastest-growing regional market, with a projected CAGR of 16.2% through 2035. Increasing regulatory development, cultivation capabilities, and consumer interest in wellness products are creating opportunities across countries including Japan, China, India, and South Korea.

The B2B channel accounted for approximately 57.6% of market value in 2025, supported by white-label production and contract manufacturing. Offline pharmacy sales are also expected to grow rapidly as regulated distribution channels expand.

Companies profiled by Market Research Future include Jazz Pharmaceuticals, Charlotte's Web Holdings, Canopy Growth Corporation, Tilray Brands, cbdMD, CV Sciences, Aurora Cannabis, Medterra CBD, Endoca, Elixinol Wellness, and NuLeaf Naturals.

With the market projected to reach USD 9.04 billion by 2035, continued regulatory development, pharmaceutical research, advanced extraction, nano-emulsion technology, veterinary applications, and expansion of pharmacy and wellness channels are expected to shape the future of the global CBD oil industry.